Neuralink Corporation, founded in 2016, is at the forefront of developing high-bandwidth brain-machine interfaces to enable direct communication between the human brain and computers.
Proprietary tech with 1,000+ patents, backed by xAI integration for superior AI synergy.
Neuralink Corporation, founded in 2016.
Neuralink invites visionary investors to join our mission to merge human intelligence with AI.
Our brain-machine interfaces are not just technology they’re the future of humanity. Secure your stake in the next era of innovation and potentially transformative returns.
Sign UpNeuralink's Groundbreaking Brain-Computer Interface Technology Poised to Transform Lives and Unlock New Possibilities.
Over 1,000 successful animal trials and first human implants underway.
Tapping into a $100B+ neurotechnology market by 2030.
Founded by Elon Musk, with partnerships in AI and biotech.
Early access to beta trials, exclusive webinars, and dividend opportunities.
Neuralink has expanded its clinical trials to multiple sites, including Canada, UK, Germany, and UAE, with 21 participants enrolled worldwide as of January 2026.
Neuralink's brain-computer interface uses AI-driven algorithms to decode neural signals, allowing for improved accuracy and adaptability in controlling devices.
Estimate your potential returns. Input the current private share price and the amount you wish to purchase to see your projected portfolio growth.
Projected Value (+20% Growth)
Our calculator uses synchronized market estimates for accurate forecasting.
All calculations are performed locally to ensure your investment strategy remains private.
Join our Neuralink Stock Investment plan and gain access to carefully selected stocks designed to help you earn steady returns.
